Ophthalmic manifestations of acute leukaemias: the ophthalmologist's role.
With evolving diagnostic and therapeutic advances, the survival of patients with acute leukaemia has considerably improved. This has led to an increase in the variability of ocular presentations in the form of side effects of the treatment and the ways leukaemic relapses are being first identified as an ocular presentation. Leukaemia may involve many ocular tissues either by direct infiltration, haemorrhage, ischaemia, or toxicity due to various chemotherapeutic agents. Ocular involvement may also be seen in graft-versus-host reaction in patients undergoing allogeneic bone marrow transplantation, or simply as increased susceptibility to infections as a result of immunosuppression that these patients undergo. This can range from simple bacterial conjunctivitis to an endophthalmitis. Leukaemia can present as pathology in the adnexae, conjunctiva, sclera, cornea, anterior chamber, iris, lens, vitreous, retina, choroid, and optic nerve. Recognition of the varied ocular presentations is also important in assessing the course and prognosis of leukaemia. We have presented a systematic approach taking each part of the eye in turn and outlining how leukaemia has been shown to affect it.
Birmingham and Midland Eye Centre, Birmingham, UK.
T
T
Sharma
J
J
Grewal
S
S
Gupta
P I
PI
Murray
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000009:adverse effects; D005123:Eye / Q000473:pathology; D005128:Eye Diseases / Q000209:etiology*; D006801:Humans; D007938:Leukemia / Q000150:complications* / Q000473:pathology; D017254:Leukemic Infiltration; D009894:Opportunistic Infections / Q000209:etiology
D000970:Antineoplastic Agents